Future therapies might include miRNA mimics or inhibitors to restore a youthful, tumor-suppressive miRNA environment, or antisense oligonucleotides (ASOs) targeting oncogenic lncRNAs like UCA1 and HOTAIR. This evidence concerns the gene UCA1 and neoplasm.